Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration
Abstract Background This study aimed to investigate the incidence of and risk factors for the anterior chamber migration of an intravitreal dexamethasone implant (Ozurdex®). Methods A retrospective review of 640 consecutive intravitreal dexamethasone implant injections was conducted from February 20...
Main Authors: | D. Röck, K. U. Bartz-Schmidt, T. Röck |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-019-1122-1 |
Similar Items
-
Anterior chamber migration of intravitreal dexamethasone implant in glued intraocular lens
by: Dhivya Ashok Kumar, et al.
Published: (2019-01-01) -
Short-term efficacy of intravitreal dexamethasone implant in vitrectomized eyes with recalcitrant diabetic macular edema and prior anti-VEGF therapy
by: Ankoor R Shah, et al.
Published: (2016-01-01) -
Anterior Chamber Migration of Ozurdex Implants
by: Özcan Kayıkcıoğlu, et al.
Published: (2020-04-01) -
Anterior chamber migration of a sustained-release dexamethasone intravitreal implant: A case report and review of literature
by: Parthopratim Dutta Majumder, et al.
Published: (2019-01-01) -
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
by: Verónica Castro-Navarro, et al.
Published: (2019-01-01)